Fumitoshi Terauchi
Koshigaya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction to: Introduction of gasless laparoscopic surgery as a minimally invasive procedure for endometrial cancer and its usefulness from the viewpoint of the learning curve.
Journal: World journal of surgical oncology
Published: February 25, 2022
Introduction of gasless laparoscopic surgery as a minimally invasive procedure for endometrial cancer and its usefulness from the viewpoint of the learning curve.
Journal: World journal of surgical oncology
Published: April 26, 2021
Krüppel-like factor 5 is upregulated and induces cell proliferation in endometrial cancer.
Journal: Oncology letters
Published: October 09, 2020
The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.
Journal: Journal of gynecologic oncology
Published: January 29, 2020
Biweekly administration of docetaxel and carboplatin for advanced or recurrent endometrial and ovarian carcinomas.
Journal: European journal of gynaecological oncology
Published: August 01, 2016
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 13, 2016
Pathological Characterization of Ovarian Cancer Patients Who Underwent Debulking Surgery in Combination With Diaphragmatic Surgery: A Cross-Sectional Study.
Journal: Medicine
Published: December 20, 2015
Profiling analysis of circulating microRNA expression in cervical cancer.
Journal: Molecular and clinical oncology
Published: December 18, 2015
Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells.
Journal: Oncology reports
Published: September 18, 2015
Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II-IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 21, 2013
Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan.
Journal: International journal of clinical oncology
Published: August 22, 2013
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial.
Journal: The Lancet. Oncology
Published: August 17, 2013
Last Updated: 09/26/2026